Renalytix plc - Sponsored ADR (RNLXY) vs Zhongchao Inc. (ZCMD)

Renalytix plc - Sponsored ADR and Zhongchao Inc. are both Health Information Services companies. Renalytix plc - Sponsored ADR is the larger, with a market value of $17.2M against $8.8M — 2.0× the size. Zhongchao Inc. grew revenue faster over the last twelve months: −6.64% against −18.3%. Zhongchao Inc. has the higher net margin (−26.2% vs −1,695.9%) and the higher return on invested capital (0.00% vs 0.00%). Across the 11 metrics below, Zhongchao Inc. leads on 8 and Renalytix plc - Sponsored ADR on 3.

Valuation

Metric RNLXY ZCMD Health Information Services median
P/E n/m n/m 39.52
P/S 3.58 n/m 2.65
P/B n/m n/m 2.32
Price to free cash flow n/m n/m 16.77
EV/EBITDA n/m 1.93 12.35
EV/Sales 2.95 (0.42) 3.06
Earnings yield (446.98%) (35.87%) (1.68%)
Free cash flow yield (273.01%) 0.00% 0.54%

Profitability

Metric RNLXY ZCMD Health Information Services median
Gross margin 14.52% 45.49% 63.38%
Operating margin (1,087.73%) 0.00% (8.35%)
Net margin (1,695.90%) (26.16%) (14.70%)
Free cash flow margin 0.00% 0.00% 0.58%
Return on equity 0.00% 0.00% (6.82%)
Return on assets 0.00% 0.00% (6.02%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric RNLXY ZCMD Health Information Services median
Revenue growth (TTM) (18.32%) (6.64%) 8.62%
EPS growth (last fiscal year) 82.14% (92.71%) —
Revenue growth, 5-year CAGR — (8.76%) 12.36%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric RNLXY ZCMD Health Information Services median
Debt to equity (5.99) 0.00 0.01
Current ratio 2.43 11.11 2.37
Net debt to EBITDA (0.26) 2.36 0.50

Dividend

Metric RNLXY ZCMD Health Information Services median
Dividend yield — — 0.85%
Payout ratio 0.00 0.00 0.00

Size

Metric RNLXY ZCMD Health Information Services median
Market cap 17.18m 8.78m 352.86m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack